All News

Among more than 10,000 women breast cancer survivors aged 65 years or older who started adjuvant endocrine therapy, those who had a mental health comorbidity were 33% more likely to use opioids.

Results of a subgroup analysis within a randomized, controlled trial show that the monoclonal antibody dupilumab (Dupixent) improved clinical and patient-reported outcomes among patients with chronic rhinosinusitis (CRS) with nasal polyps and comorbid asthma.

The price for Otezla is higher than many analysts expected.

The findings suggest that a commonly used diabetes therapy, metformin, could be used to target specific proteins that trigger DNA repair.

Quitting smoking can reduce a heavy smoker’s risk of heart disease within 5 years.

CDC continues to investigate growing cases of lung illnesses for possible correlations to vape usage; a study suggests steroid inhaler use in patients with mild asthma may be ineffective; Oklahoma judge set to decide opioid lawsuit against Johnson & Johnson today.

A study of pairs of twins revealed that obstructive sleep apnea and measures of the disorder seem to be heritable, but daytime sleepiness is mostly influenced by environmental factors.

As health costs continue to increase, health spending by families with large employer health plans has increased 2 times faster than workers’ wages over the last 10 years.

Cancer treatment raises the risk of heart disease in childhood cancer survivors, as does diabetes and hypertension.

Adding measurement of a key protein during metabolic assessment could help identify those at higher risk of heart attacks and strokes even if they have normal body mass index.

An analysis of data from between 2010 and 2017 found that Medicaid expansion promoted HIV testing without increasing HIV risk behavior among nonelderly adults.

Between 2017 and 2018, the percentage of adolescents who were up-to-date on the vaccine series increased from 48.6% to 51.1%, which was attributed to an increase among boys only.

Studies on anticoagulants and SGLT2 inhibitors, and guidelines for dyslipidemia and more are anticipated at the meeting.

Finding a cure for pancreatic cancer, which is among the deadliest cancers, will require both systemic therapy and local therapy, researchers said.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Fatal adverse events (AEs) associated with alemtuzumab for multiple sclerosis (MS) may occur more frequently than previously understood based on past published literature, researchers found.

Health insurers are planning to expand their Affordable Care Act (ACA) plan offerings next year; a 4-in-1 pill can cut the risk of heart attacks and strokes; employers can see substantial savings with biosimilars if they implement a targeted effort to ecourage biosimilar use.

This week in managed care, the top news included outcomes results in treating heart failure; US prevention experts said more women should get BRCA testing; the American Heart Association offered an advisory on treating high triglycerides with prescription omega-3 fatty acids.

The proposed changes would implement revisions to the 4-decade-old 42 CFR Part 2, which requires confidentiality of patient records created by federally-assisted substance use disorder treatment programs.

Women participating in a randomized clinical trial were able to significantly reduce their alcohol intake regardless of medication assignment and subsequently improve rates of viral suppression.

A new study has found a dose-dependent relationship between coffee consumption and reduced severity of tremors in men with Parkinson disease.

Women who reach menopause at an early age had a 31% increased risk of all-cause mortality if they had ever used hormone replacement therapy.

The findings suggest that all patients with monoclonal gammopathy of underdetermined significance should have annual blood testing to monitor whether risk of cancer change over time.

Findings appeared this month in the Journal of the American Academy of Dermatology.

Researchers found evidence correlating toxic air pollutants to increased respiratory and cardiovascular death rates.

Regeneron released positive phase 3 results for evinacumab, a drug for a rare form of deadly high cholesterol, and said it expects to seek FDA approval in 2020.

Rising troponin levels after exercise can help identify those at risk of cardiovascular disease or early death; the findings do not mean exercise is harmful.

Gilead Sciences is challenging US government patents on the HIV prevention pill Truvada; states that expanded Medicaid saw bigger increases in prescriptions for opioid addiction treatment; the National Institutes of Health (NIH) will soon begin to share the genetic analyses of nearly 200,000 people who have participated in the “All of Us” precision medicine project.